Zeria Pharmaceutical Co (TSE:4559) Cash Flow for Dividends: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4559 Zeria Pharmaceutical Co Ltd TSE:4559
85 GF Score
Price 円2,087.00
GF Value 円2,506.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zeria Pharmaceutical Co Cash Flow for Dividends?

Zeria Pharmaceutical Co TSE:4559 +1.61% 85 Cash Flow for Dividends is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4559 with a GF Score™ of 85/100 and a GF Value™ of 円2,506.68 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Zeria Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2026 was 円0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Zeria Pharmaceutical Co's annual payment of dividends increased from Mar. 2024 (円-1,935 Mil) to Mar. 2025 (円-1,977 Mil) and increased from Mar. 2025 (円-1,977 Mil) to Mar. 2026 (円-2,109 Mil).

Zeria Pharmaceutical Co Cash Flow for Dividends Related Terms

Zeria Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Zeria Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co Cash Flow for Dividends Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,538.12 -1,590.00 -1,935.40 -1,976.76 -2,109.40

Zeria Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4559
85GF Score
Zeria Pharmaceutical Co Ltd TSE:4559
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeria Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of 円0 Mil mean?
Zeria Pharmaceutical Co (TSE:4559) has a Cash Flow for Dividends of 円0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's Cash Flow for Dividends too high?
Zeria Pharmaceutical Co's current Cash Flow for Dividends is 円0 Mil. Overall, Zeria Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Zeria Pharmaceutical Co's Cash Flow for Dividends of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current Cash Flow for Dividends is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,506.68, compared to a current price of 円2,087.00 — trading 16.7% below its estimated fair value. The current Cash Flow for Dividends is 円0 Mil. Zeria Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current Cash Flow for Dividends is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?

Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,087.00 is trading 16.7% below its estimated GF Value™ of 円2,506.68. GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4559:

  • Cash Flow for Dividends: 円0 Mil
  • GF Value™: 円2,506.68 vs. price of 円2,087.00 (16.7% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeria Pharmaceutical Co Business Description

Address 10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
85GF Score

Get the complete analysis for TSE:4559

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,087.00
Price
円2,506.68
GF Value